INTRODUCTION
The Ca2+-and phospholipid-dependent enzyme protein kinase C (PKC) consists of a family of closely related isoenzymes that mediate a wide range of signal transduction processes. The ten isoenzymes that have been currently identified, PKCs-a, -l,, -/I, -y, -d, -e, -_, -sq, -0, -A, can be divided into three families on the basis oftheir different requirements for activation [1] [2] [3] [4] . Members of the conventional PKC family (PKC isoenzymes PKCs-a, -/%, -/1,, -y) are Ca2+-and phospholipid-dependent and are activated by diacylglycerols and phorbol esters, whereas enzymes in the new PKC family (PKC isoenzymes PKCs-8, -e, -y, -6) are Ca2+_ independent. Members of the atypical PKC family (PKC-C and PKC-A) have yet to be fully characterized, but PKC-C is insensitive to stimulation by Ca2+, diacylglycerol and phorbol esters [2] . The isoenzyme is, however, activated by phosphatidylinositol 3,4,5-trisphosphate 15] .
The functional significance of the existence of so many closely related enzymes is not yet understood. Immunological studies of protein expression have shown that the isoenzymes vary both in distribution between different cell types and in intracellular localization (see for example [6, 7] ). Increasing evidence suggests that different extracellular signals will generate distinct patterns of lipid activators of PKC (arachidonic acid, diacylglycerols, phospholipids) within the cell. The responses of PKC isoenzymes to these activators [1] suggest that particular isoenzymes may be preferentially activated by distinct extracellular ligands. The composition of lipid activators generated in response to these signals, as well as the intra-and inter-cellular distribution of the PKC isoenzymes, could determine which isoenzymes are involved in mediating particular signal-transduction pathways.
The difficulties in determining the significance and relative importance of the various isoenzymes are, in part, due to the absence of PKC-isoenzyme-specific activators or inhibitors. A series of potent and selective bisindolylmaleimide inhibitors of protein kinase C derived from the structural lead provided by the non-selective protein kinase inhibitor, staurosporine, have recently been described [8] . We report here the inhibition of PKCgated showed slight selectivity for PKC-a over the other isoenzymes examined. In addition, bisindolylmaleimides bearing a conformationally restricted side-chain were less active as inhibitors of PKC-e. Most noticeable of these was Ro 32-0432, which showed a 10-fold selectivity for PKC-a and a 4-fold selectivity for PKC-,8l over PKC-e. a, PKC-,fi, PKC-,fl1, PKC-y and PKC-e by a number of these compounds.
MATERIALS AND METHODS Materials
[y-32P]ATP was obtained from Amersham International p.l.c., trypsin from Washington and staurosporine from Fluka. Peptidey was supplied by P.J.P. [9] . All other biochemicals were purchased from Sigma Chemical Co. Bisindolylmaleimides were synthesized by Roche Products Ltd.
Purification of rat brain PKC Rat brain PKC was partially purified by ion-exchange chromatography, as previously described [9] .
Purification of PKC Isoenzymes PKC isoenzymes were purified by P.J.P., as previously described [10, 11] .
Assay of PKC activity Assay mixtures contained 0.2 mg/ml peptide-y, 10 ,M MgCl2, 0.6 mM CaCl2, 10 l,M [y-32P]ATP, 1.25 mg/ml phosphatidylserine and 1.25 ng/ml phorbol 12-myristate 13-acetate in 20 mM Hepes (pH 7.5), 2 mM EDTA, 1 mM dithiothreitol and 0.02 % (w/v) Triton X-100. Peptide-y is a synthetic peptide, GPRPLFC-RKGSLRQKW, resembling the PKC-y pseudosubstrate site, except that a serine residue replaces the pseudosubstrate alanine, converting the peptide from an inhibitor into a substrate [12] . The assays were started by the addition of 2.5 m-units of enzyme, incubated at 30°C for 10 min and terminated by spotting on to P81 paper (Whatman), followed by extensive washing in 75 mM orthophosphoric acid. The papers were then washed in ethanol, dried, and incorporated radioactivity was determined by liquidscintillation spectroscopy. PKC-/311 with a K, of 11.8 nM (Figure 2 ). Further evidence that these compounds bind to the catalytic domain of PKC was provided from inhibition studies using protein kinase M, the Ca2+-and phospholipid-independent catalytic fragment of PKC, which is fully functional in the absence of phorbol ester. Protein kinase M was generated by limited proteolytic cleavage of PKC-/l11 by trypsin. [9, 17] , although again these differences may not be marked enough to be translated into cellular systems. IC50 values would be expected to differ if the various processes are mediated through distinct isoenzymes. The indolocarbazole, K252a has been reported to show a high degree of selectivity for the conventional PKC isoenzymes (PKCs-a, -/3, -y) over PKC4 and PKC-e [18] . Although K252a, unlike the bisindolylmaleimides described in this paper, is not selective for PKC over other serine/threonine kinases [19] , this observation suggests that there is a potential for the design ofhighly selective bisindolylmaleimide PKC inhibitors of protein kinase C that will also show a high degree of selectivity for particular PKC isoenzymes.
